Case Report: Administration of empirical antimicrobial therapy on an acute stroke patient with Suspected Hospital-Acquired Infection
DOI:
https://doi.org/10.22437/proca.v1i2.50315Keywords:
Acute stroke care; hospital-acquired infection; c-reactive protein; antimicrobial resistanceAbstract
Background: Principles of stroke management has established several aspects that can improve or worsen patient’s clinical neurological status and overall outcome. One of the factors that can significantly affect patient outcome is hospital-acquired infection (HAI). Objective: This case report aims to illustrate how a stroke patient seems to develop HAI, which hinders the progress of clinical improvement. Methods: A 53-year-old male patient presents with sudden onset of right-sided weakness and inability to speak five days ago. Patient is also somnolent, with dysphagia and global aphasia. Patient undergoes the workup for acute onset stroke, and the clinical, radiology and laboratory data is observed. Patient is diagnosed with left middle cerebral artery territory ischemia, with the risk faktor of hypercholesterolemia and stage 1 hypertension. Patient gradually gained full consciousness, can understand verbal commands, and can swallow soft foods. On the fourth day of inpatient stay, patient develops a fever. Additional tests are then ordered to investigate the suspected HAI, including inflammation and infection markers. Results: Patient showed elevated leukocyte levels specifically neutrophilia, elevated CRP, clear chest radiography. Hospital stay is lengthened for three more days on account of intravenous administration of empirical antibiotics, continued with oral antibiotics as blood culture results is awaited. No microbial growth was found on blood culture. Conclusion: This case highlights the challenges of administering empirical antimicrobial therapy on patients that show signs of inflammation caused by bacterial infection, which interferes with the main condition’s clinical progression. Several points may be taken into consideration to design a protocol that can manage such cases more efficiently and appropriately.
Downloads
References
[1] Westendorp WF, World Health Organization. Report on the burden of endemic health care-associated infection worldwide. Geneva: WHO; 2011. Available from: https://apps.who.int/iris/handle/10665/80135
[2] Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, et al. Medical complications after stroke: a multicenter study. Stroke. 2000;31(6):1223–9
[3] Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury–induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6(10):775–86.
[4] Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1–like immunostimulation. J Exp Med. 2003;198(5):725–36.
[5] Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: Incidence, diagnosis, and pulmonary complications. Stroke. 2005;36(12):2756–63
[6] Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8(7):401–10
[7] Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR. Pneumonia and urinary tract infection after acute ischaemic stroke: A tertiary analysis of the GAIN International trial. Eur J Neurol. 2004;11(1):49–53
[8] Finlayson O, Kapral M, Hall R, Asllani E, Selchen D, Saposnik G. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology. 2011;77(14):1338–45.
[9] Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines. Clin Infect Dis. 2016;63(5):e61–e111.
[10] Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.
[11] Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines. Clin Infect Dis. 2010;50(5):625–663.
[12] Paterson DL. “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004;38(Suppl 4):S341–S345.
[13] Kanj SS, Kanafani ZA. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum β-lactamase–producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc. 2011;86(3):250–259.
[14] Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–1812.
[15] Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
[16] Lobo SM, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest.2003;123(6):2043–2049.
[17] Idicula TT, et al. Serum C-reactive protein and stroke outcome: the Bergen stroke study. Stroke. 2009;40(5):1810–1816.
[18] Hoffmann S, et al. C-reactive protein and white blood cell count in the differentiation of infectious and noninfectious fever after stroke. BMC Neurol. 2017;17(1):201.
[19] Lamy B, Dargère S, Arendrup MC, Parienti JJ, Tattevin P. How to optimize the use of blood cultures for the diagnosis of bloodstream infections? A state-of-the-art. Clin Microbiol Infect. 2016;22(4):301–307.
[20] Weinstein MP. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol. 2003;41(6):2275–2278.
[21] Opota O, Croxatto A, Prod’hom G, Greub G. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect. 2015;21(4):313–322.
[22] Kirn TJ, Weinstein MP. Update on blood cultures: how to obtain, process, report, and interpret. Clin Microbiol Infect. 2013;19(6):513–520.
[23] Riedel S, Carroll KC. Blood cultures: key elements for best practices and future directions. J Infect Chemother. 2010;16(5):301–316.
[24] Kalra L, Irshad S, Hodsoll J, Simpson M, Gulliford M, Smithard D. Prophylactic antibiotics after acute stroke for reducing pneumonia: A systematic review and meta-analysis. BMJ Open. 2017;7(9):e017617
[25] Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet. 2002;359(9319):834–40
[26] Smith CJ, Kishore AK, Vail A, Chamorro Á, Garau J, Hopkins SJ, et al. Diagnosis of stroke-associated pneumonia: Recommendations from the Pneumonia in Stroke Consensus Group. Stroke. 2015;46(8):2335–40
[27] Vermeij JD, Westendorp WF, Dippel DW, van de Beek D, Nederkoorn PJ. Antibiotic therapy for preventing infections in people with acute stroke. Cochrane Database Syst Rev. 2018;(1):CD008530
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Yuliawati, Mirna Marhami Iskandar, Fitrianingsih, Kamariyah, Attiya Istarini
This work is licensed under a Creative Commons Attribution 4.0 International License.
Published with license by LPPM Universitas Jambi. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0 International). This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator.
